Display options
Share it on

Bioinformation. 2017 Mar 31;13(3):78-85. doi: 10.6026/97320630013078. eCollection 2017.

Identification and characterization of a cyclosporin binding cyclophilin from Staphylococcus aureus Newman.

Bioinformation

Soumitra Polley, Soham Seal, Avisek Mahapa, Biswanath Jana, Anindya Biswas, Sukhendu Mandal, Debabrata Sinha, Keya Sau, Subrata Sau

Affiliations

  1. Department of Biochemistry, Bose Institute, Kolkata, West Bengal, India.
  2. Department of Biotechnology, Haldia Institute of Technology, Haldia, West Bengal, India.

PMID: 28584448 PMCID: PMC5450249 DOI: 10.6026/97320630013078

Abstract

Cyclophilins, a class of peptidyl-prolyl cis-trans isomerase (PPIase) enzymes, are inhibited by cyclosporin A (CsA), an immunosuppressive drug. Staphylococcus aureus Newman, a pathogenic bacterium, carries a gene for encoding a putative cyclophilin (SaCyp). SaCyp shows significant homology with other cyclophilins at the sequence level. A three-dimensional model structure of SaCyp harbors a binding site for CsA. To verify whether SaCyp possesses both the PPIase activity and the CsA binding ability, we have purified and investigated a recombinant SaCyp (rCyp) using various in vitro tools. Our RNase T1 refolding assay indicates that rCyp has a substantial extent of PPIase activity. rCyp that exists as a monomer in the aqueous solution is truly a cyclophilin as its catalytic activity specifically shows sensitivity to CsA. rCyp appears to bind CsA with a reasonably high affinity. Additional investigations reveal that binding of CsA to rCyp alters its structure and shape to some extent. Both rCyp and rCyp-CsA are unfolded via the formation of at least one intermediate in the presence of guanidine hydrochloride. Unfolding study also indicates that there is substantial extent of thermodynamic stabilization of rCyp in the presence of CsA as well. The data suggest that rCyp may be exploited to screen the new antimicrobial agents in the future.

Keywords: GdnCl; Staphylococcus aureus; cyclophilin; cyclosporin A; intermediate; stability; unfolding

References

  1. Int J Biol Macromol. 2014 Aug;69:353-60 - PubMed
  2. Biochemistry. 2012 Feb 14;51(6):1223-37 - PubMed
  3. J Bacteriol. 2006 Oct;188(19):6739-56 - PubMed
  4. Anal Biochem. 2013 Dec 1;443(1):52-7 - PubMed
  5. Microbiol Mol Biol Rev. 2014 Sep;78(3):544-71 - PubMed
  6. Nucleic Acids Res. 2009 Jan;37(Database issue):D455-8 - PubMed
  7. Arch Biochem Biophys. 2013 Mar;531(1-2):4-13 - PubMed
  8. J Bacteriol. 2008 Jan;190(1):300-10 - PubMed
  9. Proc Natl Acad Sci U S A. 1993 Dec 15;90(24):11850-4 - PubMed
  10. Proteins. 2000;Suppl 4:1-7 - PubMed
  11. Mol Biosyst. 2007 Feb;3(2):88-99 - PubMed
  12. PLoS One. 2014 Jul 29;9(7):e102891 - PubMed
  13. J Comput Chem. 2005 Dec;26(16):1668-88 - PubMed
  14. FEBS Lett. 2006 Dec 22;580(30):6846-60 - PubMed
  15. Antimicrob Agents Chemother. 2015 Dec 28;60(3):1656-66 - PubMed
  16. Toxicol Appl Pharmacol. 2011 Dec 15;257(3):319-27 - PubMed
  17. Anal Biochem. 2011 Apr 1;411(1):155-7 - PubMed

Publication Types